NO20003145L - Process for the preparation of paroxetine hydrochloride - Google Patents

Process for the preparation of paroxetine hydrochloride

Info

Publication number
NO20003145L
NO20003145L NO20003145A NO20003145A NO20003145L NO 20003145 L NO20003145 L NO 20003145L NO 20003145 A NO20003145 A NO 20003145A NO 20003145 A NO20003145 A NO 20003145A NO 20003145 L NO20003145 L NO 20003145L
Authority
NO
Norway
Prior art keywords
paroxetine hydrochloride
preparation
propan
solution
solvate
Prior art date
Application number
NO20003145A
Other languages
Norwegian (no)
Other versions
NO20003145D0 (en
Inventor
Neal Ward
Alan David Jones
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20003145D0 publication Critical patent/NO20003145D0/en
Publication of NO20003145L publication Critical patent/NO20003145L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

En fremgangsmåte for fremstilling av paroxetine-hydroklorid propan-2-ol- solvat omfatter dannelse av en løsning av paroxetine-hydroklorid i en blanding av propan-2-ol og et effektivt co-løsningsmiddel og krystallisering av paroxetine-hydroklorid propan-2-ol-solvat fra løsningen.A process for the preparation of paroxetine hydrochloride propan-2-ol solvate comprises the formation of a solution of paroxetine hydrochloride in a mixture of propan-2-ol and an effective co-solvent and crystallization of paroxetine hydrochloride propan-2-ol. -solvate from the solution.

NO20003145A 1997-12-19 2000-06-16 Process for the preparation of paroxetine hydrochloride NO20003145L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726907.0A GB9726907D0 (en) 1997-12-19 1997-12-19 Novel compounds
PCT/GB1998/003836 WO1999032484A1 (en) 1997-12-19 1998-12-18 Process for the preparation of paroxetine hydrochloride

Publications (2)

Publication Number Publication Date
NO20003145D0 NO20003145D0 (en) 2000-06-16
NO20003145L true NO20003145L (en) 2000-06-16

Family

ID=10823933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003145A NO20003145L (en) 1997-12-19 2000-06-16 Process for the preparation of paroxetine hydrochloride

Country Status (20)

Country Link
EP (1) EP1042318A1 (en)
JP (1) JP2001526288A (en)
KR (1) KR20010033317A (en)
CN (1) CN1281448A (en)
AP (1) AP2000001836A0 (en)
AU (1) AU1769899A (en)
BG (1) BG104604A (en)
BR (1) BR9813638A (en)
CA (1) CA2315066A1 (en)
EA (1) EA200000689A1 (en)
GB (1) GB9726907D0 (en)
HU (1) HUP0004503A3 (en)
ID (1) ID24733A (en)
IL (1) IL136590A0 (en)
NO (1) NO20003145L (en)
OA (1) OA11635A (en)
PL (1) PL341358A1 (en)
SK (1) SK9242000A3 (en)
TR (1) TR200001933T2 (en)
WO (1) WO1999032484A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
NL1017421C2 (en) 2001-02-21 2002-01-15 Synthon Bv Process for the production of paroxetine.
AU2002259114A1 (en) * 2002-02-22 2003-09-09 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
KR100672184B1 (en) 2004-09-21 2007-01-19 주식회사종근당 Paroxetine cholate or cholic acid derivative salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc New forms of parotexin hydrochloride
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride

Also Published As

Publication number Publication date
CN1281448A (en) 2001-01-24
WO1999032484A1 (en) 1999-07-01
EP1042318A1 (en) 2000-10-11
IL136590A0 (en) 2001-06-14
SK9242000A3 (en) 2001-01-18
ID24733A (en) 2000-08-03
TR200001933T2 (en) 2000-12-21
CA2315066A1 (en) 1999-07-01
AP2000001836A0 (en) 2000-06-30
PL341358A1 (en) 2001-04-09
OA11635A (en) 2004-11-22
BR9813638A (en) 2000-10-17
NO20003145D0 (en) 2000-06-16
GB9726907D0 (en) 1998-02-18
HUP0004503A2 (en) 2002-03-28
JP2001526288A (en) 2001-12-18
AU1769899A (en) 1999-07-12
BG104604A (en) 2001-03-30
KR20010033317A (en) 2001-04-25
HUP0004503A3 (en) 2002-04-29
EA200000689A1 (en) 2000-12-25

Similar Documents

Publication Publication Date Title
NO970939D0 (en) Process for the preparation of paroxetine hydrochloride anhydrate
NO973479L (en) Substituted heterocyclic compounds, method of preparation and pharmaceutical compositions containing the same
NO994706L (en) Pharmaceutical composition for oral administration of an N-piperidino-3-pyrazole carboxyamide derivative, as well as salts and solvates thereof
IS4635A (en) 4-Phenylaminothiazole derivatives, method of producing them and pharmaceutical compositions containing them
PT923554E (en) N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES
NO993500D0 (en) Tools and Procedures for Removing Surplus Cement from the Top of an Extension Row After Suspending and Cementing This
ATE133179T1 (en) STEROID SULFATASE INHIBITORS
ITBO930476A0 (en) METHOD AND MACHINE FOR MAKING DOUBLE PACKETS OF CIGARETTES
YU48698A (en) Carboxamide derivatives of pyrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorder
HUP0100760A3 (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives, process for producing them and pharmaceutical compositions containing them
NO961000D0 (en) Piperidine derivatives, process for their preparation and drug and preparation containing them
ATE267602T1 (en) 2-METHYL-THIENO-BENZODIAZEPINE FORMULATION
NO20003145L (en) Process for the preparation of paroxetine hydrochloride
NO964192L (en) Process for producing an insulator and an insulator made by the method
EE9700301A (en) Process for obtaining ropivacaine hydrochloride monohydrate
NO993011L (en) Process for the preparation of physostigmine carbamate derivatives from eseroline ethers
IT1277329B1 (en) PROCEDURE FOR THE METHYLATION OF 2,2,6,6-TETRAMETHYL-4-PIPERIDONE (TRIACETONAMINE)
NO943826D0 (en) Heteroberl piperidines, process for preparation and pharmaceutical compositions where present
MXPA02007005A (en) PSEUDOPOLYMORPH OF ()CIS2(2CHLOROPHENYL)5, 7DIHYDROXY8[4R(3SHYDROXY1METHYL)PIPERIDINYL]4Hminu s;1BENZOPYRAN4ONE.
MXPA02006965A (en) ETHANOL SOLVATE OF ()CIS2(2CHLOROPHENYL)5, 7DIHYDROXY8[4R(3SHYDROXY1METHYL)PIPERIDINYL]4Hminu s;1BENZOPYRAN4ONE.
AU6396199A (en) Method for successful early weaning of very young swine
ES2149726A1 (en) New paroxetine hydrochloride anhydrate free of propan-2-ol
HU1000354D0 (en) Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application